EditorialPublished 2 Nov 2021
Enzyme-Inducing Anti-Seizure Medications Increase Risk of Ischemic Coronary and Cerebrovascular Diseases in the Long-Term
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Comorbidity between epilepsy and cardiac diseases is frequent. Some Anti- Seizure Medications (ASMs) are associated with an increased risk of cardiac diseases. Enzyme-Inducer ASMs (EI-ASMs) have detrimental effects on some metabolic parameters that promote Atherosclerosis, including homocysteine, serum lipids, C-reactive protein, and uric acid. In a recent study, it has been demonstrated that EI-ASMs are associated with an increased risk of cardiac and cerebrovascular diseases.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Basic and Clinical Pharmacy
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gaetano Zaccara”